When You Need to Know: Why Qorvo Biotechnologies Omnia Platform Is a Better Fit for COVID Testing
Oct. 4, 2022
COVID-19 is transitioning to an endemic state where testing for this disease must be simplified to catch outbreaks as soon as possible. Organizations can no longer wait for complicated molecular tests and the length of time it takes to get a result. The endemic state of the virus demands the speed and simplicity of antigen-based point-of-care tests that deliver quick results. Unfortunately, not all tests are created equal.
